Table 1 Patients’ sociodemographic and clinical characteristics and their relationships with decisional conflict (N = 117).

Gender

 Male

92 (78.6)

2.70 (1.62)

59.93

 − 0.61

 Female

25 (21.4)

2.60 (1.58)

55.58

Age (years)

56.1 (11.2)

 − 3.73**

  < 65

87 (74.4)

3.97 (1.52)

65.37

  ≥ 65

30 (25.6)

1.80 (1.54)

40.63

Education (years)

11.9 (3.9)

 Below college

74 (63.2)

2.31 (1.67)

51.94

 − 3.18**

 College or university

43 (36.8)

3.30 (1.26)

71.15

Marital status

 Married

90 (76.9)

2.60 (1.59)

65.13

 − 1.15

 Unmarried

27 (23.1)

2.93 (1.66)

57.16

Time since diagnosis

  < 12 month

48 (41.0)

2.54 (1.62)

56.79

 − 0.63

≧12 month

69 (59.0)

2.77 (1.59)

60.54

Cancer type

 Head and neck cancer

60 (51.3)

2.83 (1.45)

60.93

 − 0.68

 Other (lung, HCC, GIST, breast, colon, pancreas, gall bladder)

57 (48.7)

2.51 (1.74)

56.96

Treatment

 Only immunotherapy

27 (23.1)

2.70 (1.46)

57.06

0.73

 Immunotherapy + chemotherapy

31 (26.5)

2.68 (1.70)

60.1

 Immunotherapy + targeted therapy

36 (30.7)

2.81 (1.60)

61.82

 Immunotherapy + chemotherapy + targeted therapy

23 (19.7)

2.43 (1.70)

55.39

Dose of treatment

 1–3 doses

68 (58.1)

2.59 (1.66)

57.78

0.57

 4–6 doses

22 (18.8)

3.00 (1.41)

65.34

  > 6 doses

27 (23.1)

2.63 (1.62)

56.91

Treatment expense

 Self-funded

72 (61.5)

2.9 (1.5)

55.65

 − 1.46

 Non-self-funded

45 (38.5)

2.5 (1.6)

64.37

Correlations with decisional conflict

r

Performance status (by ECOG)

1.43 (0.83)

 − 0.22*